Abstract:Proteinase A (PrA) is one of the most significant vacuolar proteinase in S. cerevisiae, and it plays an important role in S. cerevisiae physiology and metabolism, especially under unfavorable environment. In this study, the differences in pyruvate kinase (PYK) level under fructose-1,6-diphosphate (FDP) induction and ATP synthesis block among SC1 (the wild-type yeast that was industrial Saccharomyces cerevisiae WZ65), SC2 ( PEP4 partial deletion) and SC3 ( PEP4 complete deletion) were examined. Results showed that the induction caused by FDP clearly increased PYK expression no matter for which strain, but the increasing effect is more significant for SC2 ( P < 0.05). The comparative results of intracellular ATP accumulation showed that the induction by FDP may be affected at the presence of PrA. The block experiment of ATP synthesis showed that PYK activities in PEP4 -modified strains are lower than that of the wild type, but the intracellular ATP levels in the wild-type one are generally higher than the PEP4 -modified strains after rotenone treatment ( P < 0.01). This implies that the effect of PrA deficiency on intracellular ATP accumulation was much more pronounced than the effect of rotenone on oxidative phosphorylation. The cell morphology of three strains was comparatively examined by means of transmission electron microscopy (TEM). The PEP4 -modified strains possessed more vacuoles, and cell structure were more integrated than the wild-type strain. Current data preliminarily indicated that the deletion of PEP4 gene in industrial S. cerevisiae WZ65 may not only affected PYK expression but also modulated the oxidative phosphorylation flux.

Characterization of a valproic acid-sensitive mutant allele of the Golgi GDP-mannose transmembrane transporter Vrg4 in Schizosaccharomyces pombe

Cell wall integrity is compromised under temperature stress in Schizosaccharomyces pombe expressing a valproic acid-sensitive vas4 mutant

The Shock of Vacuolar PrA on Glycolytic Flux, Oxidative Phosphorylation, and Cell Morphology by Industrial Saccharomyces Cerevisiae WZ65

Valproic Acid Influences MTNR1A Intracellular Trafficking and Signaling in a β-Arrestin 2-Dependent Manner

Effect of PrA encoding gene- PEP4 deletion in industrial S . cerevisiae WZ65 on key enzymes in relation to the glycolytic pathway

Biochemical characterization of a GDP-mannose transporter from Chaetomium thermophilum

Identification of Aromatic Amino Acid Residues in Conserved Region VI of the Large Polymerase of Vesicular Stomatitis Virus is Essential for Both Guanine-N-7 and Ribose 2'-O Methyltransferases.

Generation and characterization of temperature-sensitive alleles encoding GPI anchored proteins Psu1 and Dfg502 in Schizosaccharomyces pombe

Deletion of Voltage-Dependent Anion Channel 1 knocks mitochondria down triggering metabolic rewiring in yeast

Monocarboxylate transporter functions and neuroprotective effects of valproic acid in experimental models of amyotrophic lateral sclerosis

Aberrant N-glycosylation is a therapeutic target in carriers of a common and highly pleiotropic mutation in the manganese transporter ZIP8

The human synaptic vesicle protein, SV2A, functions as a galactose transporter in Saccharomyces cerevisiae

Molecular study on the role of vacuolar transporters in glycyrrhetinic acid production in engineered Saccharomyces cerevisiae.

Unraveling the functional consequences of a novel germline missense mutation (R38C) in the yeast model of succinate dehydrogenase subunit B: insights into neurodegenerative disorders

Advances in targeting the vacuolar proton-translocating ATPase (V-ATPase) for anti-fungal therapy

Mutations adjacent to the end of transmembrane helices 6 and 7 independently affect drug efflux capacity of yeast ABC transporter Pdr5p.

Role of palmitoylation on the neuronal glycine transporter GlyT2

A Mutation In Intracellular Loop 4 Affects The Drug-Efflux Activity Of The Yeast Multidrug Resistance Abc Transporter Pdr5p

Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients

Valproic acid is protective in cellular and worm models of oculopharyngeal muscular dystrophy.

Valproic acid-induced teratogenicity is driven by senescence and prevented by Rapamycin in human spinal cord and animal models